Prophylactic use of lamivudine with chronic immunosuppressive therapy for rheumatologic disorders

Rheumatology International

Volumn 29, Issue 7, 2009, Pages 777-780

  Kalyoncu, Umut ^a   Yonem, Ozlem ^a   Calguneri, Meral ^a   Ersoy, Osman ^a   Karadag, Omer ^a   Akdogan, Ali ^a   Bilgen, Sule A ^a   Kiraz, Sedat ^a   Ertenli, Ihsan ^a   Bayraktar, Yusuf ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Hepatitis B; Immunosuppressive therapy; Lamivudine

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; HEPATITIS B SURFACE ANTIGEN; HYDROXYCHLOROQUINE; INFLIXIMAB; LAMIVUDINE; LEFLUNOMIDE; METHOTREXATE; SALAZOSULFAPYRIDINE; STEROID; VIRUS DNA;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANAPHYLACTOID PURPURA; ANKYLOSING SPONDYLITIS; AORTA ARCH SYNDROME; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; DISEASE DURATION; ECHOGRAPHY; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER FUNCTION TEST; MALE; MEDICAL RECORD REVIEW; POLYMYOSITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS REACTIVATION;

ADULT; AGED; BIOLOGICAL MARKERS; DNA, VIRAL; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; LAMIVUDINE; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE INHIBITORS; RHEUMATIC DISEASES; TREATMENT OUTCOME; VIRAL LOAD;

EID: 67349120329     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-008-0790-6     Document Type: Article

References (12)

1. D Mehmet E Meliksah Y Serif S Gunay O Tuncer S Zeynep 2005 Prevalence of hepatitis B infection in the southeastern region of Turkey: comparison of risk factors for HBV infection in rural and urban areas Jpn J Infect Dis 58 1 15 19
2. W Yeo PK Chan S Zhong WM Ho JL Steinberg JS Tam P Hui NW Leung B Zee PJ Johnson 2000 Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors J Med Virol 62 3 299 307
3. LH Calabrese NN Zein D Vassilopoulos 2006 Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies Ann Rheum Dis 65 8 983 989
4. T Vassiliadis V Garipidou K Tziomalos V Perifanis O Giouleme S Vakalopoulou 2005 Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy a prospective case series Am J Hematol 80 3 197 203
5. S Gupta S Govindarajan TL Fong AG Redeker 1990 Spontaneous reactivation in chronic hepatitis B: patterns and natural history J Clin Gastroenterol 12 5 562 568
6. R Tur-Kaspa RD Burk Y Shaul DA Shafritz 1986 Hepatitis B virus DNA contains a glucocorticoid-responsive element Proc Natl Acad Sci USA 83 6 1627 1631
7. AL Cheng CA Hsiung IJ Su PJ Chen MC Chang CJ Tsao WY Kao WC Uen CH Hsu HF Tien TY Chao LT Chen J Whang-Peng 2003 Lymphoma Committee of Taiwan Cooperative Oncology Group Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma Hepatology 37 6 1320 1328
8. AL Cheng 1996 Steroid-free chemotherapy decreases the risk of hepatitis flare-up in hepatitis B virus carriers with non-Hodgkin's lymphoma Blood 87 3 1202
9. V Di Marco A Marzano P Lampertico P Andreone T Santantonio PL Almasio M Rizzetto A Craxi 2004 Italian Association for the Study of the Liver (AISF) Lamivudine Study Group, Italy. Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine Hepatology 40 4 883 891
10. F Fabrizi G Dulai V Dixit S Bunnapradist P Martin 2004 Lamivudine for the treatment of hepatitis B virus-related liver disease after renal transplantation: meta-analysis of clinical trials Transplantation 77 6 859 864
11. A Berger W Preiser HG Kachel M Sturmer HW Doerr 2005 HBV reactivation after kidney transplantation J Clin Virol 32 2 162 165
12. FC Tsai SC Hsieh DS Chen JC Sheu DS Chen 2006 Reactivation of hepatitis B virus in rheumatologic patients receiving immunosuppressive agents Dig Dis Sci 51 1627 1632